Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Constipation, polyps, or cancer? Let PTEN predict your future.

Charis Eng1

  • 1Clinical Cancer Genetics Program and Human Cancer Genetics Program, Comprehensive Cancer Center, Division of Human Genetics, Department of Internal Medicine, The Ohio State University, Columbus, Ohio 43210, USA. eng-1@medctr.osu.edu

American Journal of Medical Genetics. Part A
|October 1, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Embryonic stem cell factor FOXD3 (Genesis) defects in gastrointestinal stromal tumors.

Endocrine-related cancer·2023
Same author

A Randomized Trial Comparing the Effectiveness of Pre-test Genetic Counseling Using an Artificial Intelligence Automated Chatbot and Traditional In-person Genetic Counseling in Women Newly Diagnosed with Breast Cancer.

Annals of surgical oncology·2023
Same author

Development of webcam-collected and artificial-intelligence-derived social and cognitive performance measures for neurodevelopmental genetic syndromes.

American journal of medical genetics. Part C, Seminars in medical genetics·2023
Same author

Hemizygous variants in protein phosphatase 1 regulatory subunit 3F (PPP1R3F) are associated with a neurodevelopmental disorder characterized by developmental delay, intellectual disability and autistic features.

Human molecular genetics·2023
Same author

Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation.

Breast cancer research and treatment·2023
Same author

Integrating somatic CNV and gene expression in breast cancers from women with PTEN hamartoma tumor syndrome.

NPJ genomic medicine·2023
Same journal

Biallelic Variants in MIMS1 Produce a Form of Spondyloepimetaphyseal Dysplasia With Tracheal Stenosis and Ectodermal Dysplasia (SEMDTSED).

American journal of medical genetics. Part A·2026
Same journal

How does Léri-Weill Dyschondrosteosis Affect Adults' Health-Related Quality of Life? - A Norwegian Cross-Sectional Study Exploring the Physical and Mental Burden.

American journal of medical genetics. Part A·2026
Same journal

Re-Identification of the Panamanian Guna/Kuna/Cuna OCA2 Founder Association Through Two American-Born Siblings.

American journal of medical genetics. Part A·2026
Same journal

Biallelic Variant in HAPLN1 is Associated With Skeletal Dysplasia With or Without Congenital Heart Disease.

American journal of medical genetics. Part A·2026
Same journal

MYH11-Related Hereditary Type 2 Visceral Myopathy in a Large Kindred: Diagnostic Odyssey With Milder Clinical Manifestations.

American journal of medical genetics. Part A·2026
Same journal

Positron Emission Tomography (PET) in Phenylketonuria: A Systematic Review of Brain Metabolism Beyond Phenylalanine.

American journal of medical genetics. Part A·2026
See all related articles

Inherited hamartoma polyposis syndromes like Cowden syndrome and Peutz-Jeghers syndrome have distinct genetic causes and cancer risks. Molecular diagnosis is crucial for managing these rare genetic conditions.

Area of Science:

  • Genetics and Molecular Biology
  • Oncology
  • Gastroenterology

Background:

  • Inherited hamartoma polyposis syndromes include Cowden syndrome (CS), Bannayan-Riley-Ruvalcaba syndrome (BRRS), juvenile polyposis syndrome (JPS), and Peutz-Jeghers syndrome (PJS).
  • These syndromes have diverse genetic underpinnings, affecting different genes such as PTEN, MADH4, BMPR1A, and LKB1 (STK11).
  • Clinical presentations and associated cancer risks vary significantly among these syndromes.

Purpose of the Study:

  • To differentiate between inherited hamartoma polyposis syndromes based on their genetic mutations.
  • To highlight the varying polyp characteristics and cancer risks associated with each syndrome.
  • To emphasize the importance of molecular-based diagnosis for effective medical management.

Main Methods:

Related Experiment Videos

  • Review of genetic mutations associated with CS, BRRS, JPS, and PJS.
  • Analysis of clinical features, including polyp types and distribution.
  • Correlation of specific gene mutations with cancer risks for each syndrome.

Main Results:

  • PTEN mutations are linked to CS (80%) and BRRS (60%), with associated risks of breast, thyroid, and endometrial cancers.
  • JPS is associated with MADH4 and BMPR1A mutations, increasing gastrointestinal cancer risk.
  • PJS is linked to LKB1 (STK11) mutations, also associated with increased gastrointestinal cancer risk.
  • Glycogenic acanthosis of the esophagus is a predictive marker for PTEN mutation-positive CS.

Conclusions:

  • Distinguishing between these syndromes through molecular diagnostics is essential for personalized medical management.
  • Understanding the specific genetic basis and associated cancer risks allows for targeted surveillance and early intervention.
  • The study underscores the heterogeneity of hamartoma polyposis syndromes and the need for precise genetic identification.